Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohns disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
Strategies for maintaining weight loss after tirzepatide include gradual dose reduction rather than abrupt cessation, established exercise habits, and nutritional patterns that support a lower body weight
Natural forms of vitamin E and metabolites-regulation of cancer cell death and underlying mechanisms
How does Zepbound affect your vision
Importantly, NICE specifies that Wegovy should only be prescribed as part of a specialist weight management service (Tier 3), with ongoing support for diet, physical activity, and behavioural change, and treatment should be limited to a maximum of 2 years